Cargando…

Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes

Somatic cells acquire stem cell-like properties during cancerous transformation; however, mechanisms through which committed cells develop stemness and malignancy remain largely unknown. Here we uncovered upregulated stem cell program in leukaemic lymphoblasts of patients with IKZF1 alterations by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhen, Li, Shui-Ping, Li, Ruo-Yan, Zhu, Hua, Liu, Xia, Guo, Xiao-Lin, Mu, Li-Li, Cai, Jie-Jing, Bai, Fan, Chen, Guo-Qiang, Hong, Deng-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943605/
https://www.ncbi.nlm.nih.gov/pubmed/29743561
http://dx.doi.org/10.1038/s41419-018-0600-3
_version_ 1783321664098926592
author Li, Zhen
Li, Shui-Ping
Li, Ruo-Yan
Zhu, Hua
Liu, Xia
Guo, Xiao-Lin
Mu, Li-Li
Cai, Jie-Jing
Bai, Fan
Chen, Guo-Qiang
Hong, Deng-Li
author_facet Li, Zhen
Li, Shui-Ping
Li, Ruo-Yan
Zhu, Hua
Liu, Xia
Guo, Xiao-Lin
Mu, Li-Li
Cai, Jie-Jing
Bai, Fan
Chen, Guo-Qiang
Hong, Deng-Li
author_sort Li, Zhen
collection PubMed
description Somatic cells acquire stem cell-like properties during cancerous transformation; however, mechanisms through which committed cells develop stemness and malignancy remain largely unknown. Here we uncovered upregulated stem cell program in leukaemic lymphoblasts of patients with IKZF1 alterations by analysing the archived gene-expression profiling datasets. We then used a frequent IKZF1 deletion, IK6, as a model via transduction into human primitive haematopoietic cells, followed by xenotransplantation in mice. Immunophenotypically defined stem, pro-B, and immature/mature (IM/M)-B cells were collected from primary recipients for functional assay and transcriptome profiling. Successful reconstitution in secondary recipient mice revealed the stemness of IK6(+) pro-B and IM/M-B cells. Upregulated stemness and malignancy programs in IK6(+) cells confirmed IK6 effects. Interestingly, these programs corresponded to distinct canonical pathways. Remarkably, the pathway profile mapped in the modelled cells well mirrored that in patients’ leukaemic cells; therefore, our study provides a seminal insight into the cancerous reprogramming of somatic cells.
format Online
Article
Text
id pubmed-5943605
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59436052018-05-10 Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes Li, Zhen Li, Shui-Ping Li, Ruo-Yan Zhu, Hua Liu, Xia Guo, Xiao-Lin Mu, Li-Li Cai, Jie-Jing Bai, Fan Chen, Guo-Qiang Hong, Deng-Li Cell Death Dis Article Somatic cells acquire stem cell-like properties during cancerous transformation; however, mechanisms through which committed cells develop stemness and malignancy remain largely unknown. Here we uncovered upregulated stem cell program in leukaemic lymphoblasts of patients with IKZF1 alterations by analysing the archived gene-expression profiling datasets. We then used a frequent IKZF1 deletion, IK6, as a model via transduction into human primitive haematopoietic cells, followed by xenotransplantation in mice. Immunophenotypically defined stem, pro-B, and immature/mature (IM/M)-B cells were collected from primary recipients for functional assay and transcriptome profiling. Successful reconstitution in secondary recipient mice revealed the stemness of IK6(+) pro-B and IM/M-B cells. Upregulated stemness and malignancy programs in IK6(+) cells confirmed IK6 effects. Interestingly, these programs corresponded to distinct canonical pathways. Remarkably, the pathway profile mapped in the modelled cells well mirrored that in patients’ leukaemic cells; therefore, our study provides a seminal insight into the cancerous reprogramming of somatic cells. Nature Publishing Group UK 2018-05-09 /pmc/articles/PMC5943605/ /pubmed/29743561 http://dx.doi.org/10.1038/s41419-018-0600-3 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Li, Zhen
Li, Shui-Ping
Li, Ruo-Yan
Zhu, Hua
Liu, Xia
Guo, Xiao-Lin
Mu, Li-Li
Cai, Jie-Jing
Bai, Fan
Chen, Guo-Qiang
Hong, Deng-Li
Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title_full Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title_fullStr Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title_full_unstemmed Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title_short Leukaemic alterations of IKZF1 prime stemness and malignancy programs in human lymphocytes
title_sort leukaemic alterations of ikzf1 prime stemness and malignancy programs in human lymphocytes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943605/
https://www.ncbi.nlm.nih.gov/pubmed/29743561
http://dx.doi.org/10.1038/s41419-018-0600-3
work_keys_str_mv AT lizhen leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT lishuiping leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT liruoyan leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT zhuhua leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT liuxia leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT guoxiaolin leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT mulili leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT caijiejing leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT baifan leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT chenguoqiang leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes
AT hongdengli leukaemicalterationsofikzf1primestemnessandmalignancyprogramsinhumanlymphocytes